Close Menu

Publishers and open-access advocates are duking it out in front of a US House of Representatives committee, reports the Chronicle of Higher Education's Jennifer Howard. The fight is over whether research paid for with federal money should be made publically accessible. Advocates say yes, but publishers are urging lawmakers not to make a hasty decision, "for fear of putting US intellectual property — and publishers' livelihoods — at risk," Howard says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has launched a new tool that estimates someone's risk of developing severe COVID-19 if infected, Bloomberg reports.

The Guardian reports that Pasteur Institute researchers are halting their development of a SARS-CoV-2 vaccine following disappointing initial results.

The Wall Street Journal reports that an increased number of younger patients have been hospitalized as the new SARS-CoV-2 strain spread across the UK.

In Cell this week: proteomic patterns among COVID-19 affected tissue samples, transcriptome atlas of developing intestines, and more.